WSJ Tech News Briefing · Thursday, October 1, 2026
The biosecurity startup Red Queen Bio is employing AI models to design antibody treatments capable of neutralizing emerging viruses and AI-designed pathogens. The company aims to rapidly develop and manufacture these countermeasures to protect against future biological threats.
“Red Queen Bio is essentially using AI to design remedies against AI-enabled bioweapons.”
“And so right now they're rushing to design antibody drugs that can be manufactured to protect against a range of potential pathogens, including this like sci-fi threat of an AI-designed virus.”
“But the company plans to focus in coming months on antibodies for coronaviruses, Ebola-like viruses, bat-borne viruses, a bunch of others.”